Skip to main content

Table 3 Conversion ratio from opioids to methadone

From: Methadone switching for refractory cancer pain

OMEDD pre-switching (mg)

Recommended initial CR

All

N (%)

Initial CR

Median (IQR)

Successful switching

 

Failure switching

N

Initial CR

Median (IQR)

Under calculated ratio

Matched calculated ratio

Over calculated ratio

 

N

Initial CR

Median (IQR)

Less than calculated ratio

Equal to calculated ratio

More than calculated ratio

All

—

90

7.3 (5.0–11.1)

64

7.3 (5.4–10.6)

39 (60.9)

9 (14.1)

16 (25.0)

 

26

7.4 (4.0–14.2)

14 (53.8)

4 (15.4)

8 (30.8)

30–90

4:1

15 (16.7)

3.3 (3.0–5.0)

9

4.0 (3.2–5.5)

4 (44.4)

2 (22.2)

3 (33.3)

 

6

3.2 (2.8–4.5)

4 (66.7)

1 (16.7)

1 (16.7)

91–300

8:1

27 (30.0)

6.0 (5.0–8.0)

16

6.0 (5.3–8.0)

10 (62.5)

3 (18.8)

3 (18.8)

 

11

6.7 (4.7–8.3)

6 (54.5)

2 (18.2)

3 (27.3)

301–600

10:1

31 (34.4)

8.0 (6.4–11.5)

26

8.0 (6.3–10.1)

17 (65.4)

4 (15.4)

5 (19.2)

 

5

16.8 (8.0–21.6)

2 (40.0)

0 (0.0)

3 (60.0)

601–800

12:1

4 (4.4)

9.2 (6.2–19.1)

3

5.6, 10.4, 22.0

2 (66.7)

0 (0.0)

1 (33.3)

 

1

8.0

1 (100.0)

0 (0.0)

0 (0.0)

801–1000

15:1

3 (3.3)

6.4, 10.7, 10.0

3

6.4, 10.7, 10.0

3 (100.0)

0 (0.0)

0 (0.0)

 

0

—

—

—

—

> 1000

20:1

10 (11.1)

22.4 (13.9–49.2)

7

24.3 (14.7–65.2)

3 (42.9)

0 (0.0)

4 (57.1)

 

3

43.8, 20.4, 11.4

1 (33.3)

1 (33.3)

1 (33.3)

  1. Note: OMEDD Oral Morphine Equivalent Daily Dose; CR Conversion Ratio; IQR Interquartile Range